Kinaset Therapeutics Doses First Patient in Phase 2b Trial of Frevecitinib for Severe Asthma Kinaset Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative inhaled therapies for serious respiratory diseases,…
Immunomic Therapeutics Doses First Patient in Phase 1 Trial of ITI-5000 Therapeutic Cancer Vaccine for Triple-Negative Breast Cancer Immunomic Therapeutics, Inc. (ITI), a clinical-stage biotechnology company and U.S.-based subsidiary of…
Clinigen Appoints Greg Skalicky as Group CEO to Lead Next Phase of Global Growth and Patient Access Strategy Clinigen, a global pharmaceutical services company dedicated to improving patient access to…
Bayer and Henry Ford Health Form Strategic Partnership to Expand Patient Access to Clinical Trials and Accelerate Medical Innovation Bayer, a global life sciences company with a broad portfolio spanning…
iVeena Delivery Systems Completes Phase 1 Trial of IVMED-85, Advancing Novel Eye Drop Therapy for Pediatric Myopia iVeena Delivery Systems, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing innovative…
Aptar Pharma Introduces Collaborative System-Level Framework to Advance Injectable Drug Delivery Development Aptar Pharma, a global leader in drug delivery, dosing, protection technologies, and pharmaceutical services, has announced the launch…
Veradermics Presents New Phase 2/3 Data Highlighting the Potential of VDPHL01 for Male Pattern Hair Loss Across Age Groups Veradermics, Incorporated, a late-stage biopharmaceutical company founded by dermatologists and dedicated…
LianMedical Completes Merger with LianBio and Launches New Chapter as Medical Device Innovation Company LianMedical, formerly known as LianBio, has announced the successful completion of its previously disclosed corporate merger,…
Takeda Reports New Phase 3 Data Showing Zasocitinib Delivers Strong Skin Clearance Across Difficult-to-Treat Areas in Plaque Psoriasis Takeda has announced new findings from its two pivotal Phase 3 clinical…
Mirador Therapeutics Expands Precision Immunology Pipeline Through Global Licensing Agreement for KP-301 Mirador Therapeutics, Inc., a clinical-stage biotechnology company focused on developing precision medicines for immune-mediated inflammatory and fibrotic diseases,…
Cutera and Restimulate Health Partner to Advance Technology-Driven Rehabilitation with truFlex Integration CUTERA, INC., a global provider of aesthetic and dermatologic technologies, has announced a strategic partnership with Restimulate Health,…
Anova Enterprises and Nouveau Biosciences Partner to Advance Clinical Development of Kromastat for Hard-to-Treat Cancers Anova Enterprises, Inc., a technology-enabled contract research organization (CRO) dedicated to accelerating the development of…